BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmidt HR, Zheng S, Gurpinar E, Koehl A, Manglik A, Kruse AC. Crystal structure of the human σ1 receptor. Nature 2016;532:527-30. [PMID: 27042935 DOI: 10.1038/nature17391] [Cited by in Crossref: 263] [Cited by in F6Publishing: 250] [Article Influence: 43.8] [Reference Citation Analysis]
Number Citing Articles
1 Laurini E, Marson D, Fermeglia M, Pricl S. 3D Homology Model of Sigma1 Receptor. In: Kim FJ, Pasternak GW, editors. Sigma Proteins: Evolution of the Concept of Sigma Receptors. Cham: Springer International Publishing; 2017. pp. 27-50. [DOI: 10.1007/164_2017_35] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
2 Xu Z, Lei Y, Qin H, Zhang S, Li P, Yao K. Sigma-1 Receptor in Retina: Neuroprotective Effects and Potential Mechanisms. IJMS 2022;23:7572. [DOI: 10.3390/ijms23147572] [Reference Citation Analysis]
3 Abatematteo FS, Niso M, Contino M, Leopoldo M, Abate C. Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives. Int J Mol Sci 2021;22:6359. [PMID: 34198620 DOI: 10.3390/ijms22126359] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mimasu S, Yamagishi H, Kubo S, Kiyohara M, Matsuda T, Yahata T, Thomson HA, Hupp CD, Liu J, Okuda T, Kakefuda K. Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition. Commun Biol 2021;4:159. [PMID: 33542467 DOI: 10.1038/s42003-021-01666-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ghani L, Munk CF, Zhang X, Katsube S, Du Y, Cecchetti C, Huang W, Bae HE, Saouros S, Ehsan M, Guan L, Liu X, Loland CJ, Kobilka BK, Byrne B, Chae PS. 1,3,5-Triazine-Cored Maltoside Amphiphiles for Membrane Protein Extraction and Stabilization. J Am Chem Soc 2019;141:19677-87. [PMID: 31809039 DOI: 10.1021/jacs.9b07883] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Arun AS, Eddings CR, Wilson KL. Novel missense alleles of SIGMAR1 as tools to understand emerin-dependent gene silencing in response to cocaine. Exp Biol Med (Maywood) 2019;244:1354-61. [PMID: 31324122 DOI: 10.1177/1535370219863444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sguazzini E, Schmidt HR, Iyer KA, Kruse AC, Dukat M. Reevaluation of fenpropimorph as a σ receptor ligand: Structure-affinity relationship studies at human σ1 receptors. Bioorg Med Chem Lett 2017;27:2912-9. [PMID: 28495085 DOI: 10.1016/j.bmcl.2017.04.088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
8 Jerčić L, Kostić S, Vitlov Uljević M, Vukušić Pušić T, Vukojević K, Filipović N. Sigma-1 Receptor Expression in DRG Neurons During a Carrageenan-Provoked Inflammation. Anat Rec (Hoboken) 2019;302:1620-7. [PMID: 30614637 DOI: 10.1002/ar.24061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Crouzier L, Denus M, Richard EM, Tavernier A, Diez C, Cubedo N, Maurice T, Delprat B. Sigma-1 Receptor Is Critical for Mitochondrial Activity and Unfolded Protein Response in Larval Zebrafish. Int J Mol Sci 2021;22:11049. [PMID: 34681705 DOI: 10.3390/ijms222011049] [Reference Citation Analysis]
10 Pati ML, Fanizza E, Hager S, Groza D, Heffeter P, Laurenza AG, Laquintana V, Curri ML, Depalo N, Abate C, Denora N. Quantum Dot Based Luminescent Nanoprobes for Sigma-2 Receptor Imaging. Mol Pharm 2018;15:458-71. [PMID: 29226684 DOI: 10.1021/acs.molpharmaceut.7b00825] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lasitza‐male T, Bartels K, Jungwirth J, Wiggers F, Rosenblum G, Hofmann H, Löw C. Membrane Chemistry Tunes the Structure of a Peptide Transporter. Angew Chem 2020;132:19283-90. [DOI: 10.1002/ange.202008226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Saito M, Murakami S, Nanjo T, Kobayashi Y, Takemoto Y. Mild and Chemoselective Thioacylation of Amines Enabled by the Nucleophilic Activation of Elemental Sulfur. J Am Chem Soc 2020;142:8130-5. [DOI: 10.1021/jacs.0c03256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
13 Voronin MV, Kadnikov IA, Voronkov DN, Seredenin SB. Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease. Sci Rep 2019;9:17020. [PMID: 31745133 DOI: 10.1038/s41598-019-53413-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ryskamp DA, Zhemkov V, Bezprozvanny I. Mutational Analysis of Sigma-1 Receptor's Role in Synaptic Stability. Front Neurosci 2019;13:1012. [PMID: 31607852 DOI: 10.3389/fnins.2019.01012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
15 Aishwarya R, Abdullah CS, Morshed M, Remex NS, Bhuiyan MS. Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology. Front Physiol 2021;12:705575. [PMID: 34305655 DOI: 10.3389/fphys.2021.705575] [Reference Citation Analysis]
16 Christ MG, Huesmann H, Nagel H, Kern A, Behl C. Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo. Cells 2019;8:E211. [PMID: 30832324 DOI: 10.3390/cells8030211] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
17 Floresta G, Amata E, Barbaraci C, Gentile D, Turnaturi R, Marrazzo A, Rescifina A. A Structure- and Ligand-Based Virtual Screening of a Database of "Small" Marine Natural Products for the Identification of "Blue" Sigma-2 Receptor Ligands. Mar Drugs 2018;16:E384. [PMID: 30322188 DOI: 10.3390/md16100384] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
18 Lipiński PFJ, Matalińska J. Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics. Int J Mol Sci 2022;23:2766. [PMID: 35269909 DOI: 10.3390/ijms23052766] [Reference Citation Analysis]
19 Gregianin E, Pallafacchina G, Zanin S, Crippa V, Rusmini P, Poletti A, Fang M, Li Z, Diano L, Petrucci A, Lispi L, Cavallaro T, Fabrizi GM, Muglia M, Boaretto F, Vettori A, Rizzuto R, Mostacciuolo ML, Vazza G. Loss-of-function mutations in the SIGMAR1 gene cause distal hereditary motor neuropathy by impairing ER-mitochondria tethering and Ca2+ signalling. Hum Mol Genet 2016;25:3741-53. [PMID: 27402882 DOI: 10.1093/hmg/ddw220] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 10.2] [Reference Citation Analysis]
20 Abraham MJ, Fleming KL, Raymond S, Wong AYC, Bergeron R. The sigma-1 receptor behaves as an atypical auxiliary subunit to modulate the functional characteristics of Kv1.2 channels expressed in HEK293 cells. Physiol Rep 2019;7:e14147. [PMID: 31222975 DOI: 10.14814/phy2.14147] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
21 Hong WC, Yano H, Hiranita T, Chin FT, McCurdy CR, Su TP, Amara SG, Katz JL. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats. J Biol Chem 2017;292:11250-61. [PMID: 28495886 DOI: 10.1074/jbc.M116.774075] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 8.4] [Reference Citation Analysis]
22 Katz JL, Hiranita T, Hong WC, Job MO, McCurdy CR. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction. Handb Exp Pharmacol 2017;244:177-218. [PMID: 28110353 DOI: 10.1007/164_2016_94] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
23 Linkens K, Schmidt HR, Sahn JJ, Kruse AC, Martin SF. Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties. European Journal of Medicinal Chemistry 2018;151:557-67. [DOI: 10.1016/j.ejmech.2018.02.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
24 Asare-nkansah S, Schepmann D, Wünsch B. Synthesis of conformationally restricted 1,3-dioxanes to analyze the bioactive conformation of 1,3-dioxane-based σ 1 and PCP receptor antagonists. Bioorganic & Medicinal Chemistry 2017;25:2472-81. [DOI: 10.1016/j.bmc.2017.03.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
25 Sambo DO, Lebowitz JJ, Khoshbouei H. The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction. Pharmacol Ther 2018;186:152-67. [PMID: 29360540 DOI: 10.1016/j.pharmthera.2018.01.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
26 Uprety R, Váradi A, Allaoa A, Redel-Traub GN, Palmer TC, Feinberg EN, Ferris AC, Pande VS, Pasternak GW, Majumdar S. Synthesis of spiro-2,6-dioxopiperazine and spiro-2,6-dioxopyrazine scaffolds using amino acids in a three-component reaction to generate potential Sigma-1 (σ1) receptor selective ligands. Eur J Med Chem 2019;164:241-51. [PMID: 30597325 DOI: 10.1016/j.ejmech.2018.12.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
27 Joubert J, Strydom N, Geldenhuys WJ, Greyling Y, V. Dyk S, Malan SF. Hexacyclododecylamines with Sigma-1 Receptor Affinity and Calcium Channel Modulating Ability. TOMCJ 2019;13:29-39. [DOI: 10.2174/1874104501913010029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 He Y, Xie F, Ye J, Deuther-Conrad W, Cui B, Wang L, Lu J, Steinbach J, Brust P, Huang Y, Lu J, Jia H. 1-(4-[18F]Fluorobenzyl)-4-[(tetrahydrofuran-2-yl)methyl]piperazine: A Novel Suitable Radioligand with Low Lipophilicity for Imaging σ1 Receptors in the Brain. J Med Chem 2017;60:4161-72. [PMID: 28409931 DOI: 10.1021/acs.jmedchem.6b01723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
29 Zhang K, Zhao Z, Lan L, Wei X, Wang L, Liu X, Yan H, Zheng J. Sigma-1 Receptor Plays a Negative Modulation on N-type Calcium Channel. Front Pharmacol 2017;8:302. [PMID: 28603497 DOI: 10.3389/fphar.2017.00302] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
30 Mangiatordi GF, Intranuovo F, Delre P, Abatematteo FS, Abate C, Niso M, Creanza TM, Ancona N, Stefanachi A, Contino M. Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration. J Med Chem 2020;63:14448-69. [PMID: 33094613 DOI: 10.1021/acs.jmedchem.0c01357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Torres-Gómez H, Daniliuc C, Schepmann D, Wünsch B. Synthesis of 3-aza[4.4.3]propellanes with high σ1 receptor affinity. Bioorg Med Chem 2018;26:1705-12. [PMID: 29482951 DOI: 10.1016/j.bmc.2018.02.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Estrada-Valencia M, Herrera-Arozamena C, Pérez C, Viña D, Morales-García JA, Pérez-Castillo A, Ramos E, Romero A, Laurini E, Pricl S, Rodríguez-Franco MI. New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties. J Enzyme Inhib Med Chem 2019;34:712-27. [PMID: 31852270 DOI: 10.1080/14756366.2019.1581184] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
33 Estrada Valencia M, Herrera-Arozamena C, de Andrés L, Pérez C, Morales-García JA, Pérez-Castillo A, Ramos E, Romero A, Viña D, Yáñez M, Laurini E, Pricl S, Rodríguez-Franco MI. Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease. Eur J Med Chem 2018;156:534-53. [PMID: 30025348 DOI: 10.1016/j.ejmech.2018.07.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
34 Zhemkov V, Ditlev JA, Lee WR, Wilson M, Liou J, Rosen MK, Bezprozvanny I. The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains. Elife 2021;10:e65192. [PMID: 33973848 DOI: 10.7554/eLife.65192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
35 Merlos M, Romero L, Zamanillo D, Plata-Salamán C, Vela JM. Sigma-1 Receptor and Pain. Handb Exp Pharmacol 2017;244:131-61. [PMID: 28275913 DOI: 10.1007/164_2017_9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
36 Navarro G, Medrano M, Aguinaga D, Vega-Quiroga I, Lillo A, Jiménez J, Casanovas M, Canela EI, Mallol J, Gysling K, Franco R. Differential effect of amphetamine over the corticotropin-releasing factor CRF2 receptor, the orexin OX1 receptor and the CRF2-OX1 heteroreceptor complex. Neuropharmacology 2019;152:102-11. [PMID: 30465812 DOI: 10.1016/j.neuropharm.2018.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
37 Sahn JJ, Mejia GL, Ray PR, Martin SF, Price TJ. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice. ACS Chem Neurosci 2017;8:1801-11. [PMID: 28644012 DOI: 10.1021/acschemneuro.7b00200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
38 Sahn JJ, Hodges TR, Chan JZ, Martin SF. Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity. ACS Med Chem Lett 2017;8:455-60. [PMID: 28435536 DOI: 10.1021/acsmedchemlett.7b00066] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
39 Bergkemper M, Schepmann D, Wünsch B. Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers. ChemMedChem 2021;16:1184-97. [PMID: 33332704 DOI: 10.1002/cmdc.202000861] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Rossi D, Rui M, Di Giacomo M, Schepmann D, Wünsch B, Monteleone S, Liedl KR, Collina S. Gaining in pan-affinity towards sigma 1 and sigma 2 receptors. SAR studies on arylalkylamines. Bioorg Med Chem 2017;25:11-9. [PMID: 27838169 DOI: 10.1016/j.bmc.2016.10.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
41 Intagliata S, Agha H, Kopajtic TA, Katz JL, Kamble SH, Sharma A, Avery BA, McCurdy CR. Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[d]thiazol-2(3H)one σ receptor ligands. Med Chem Res 2020;29:1697-706. [PMID: 33584084 DOI: 10.1007/s00044-020-02597-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Paniagua N, Goicoechea C, Abalo R, López-Miranda V, Vela JM, Merlos M, Martín Fontelles MI, Girón R. May a sigma-1 antagonist improve neuropathic signs induced by cisplatin and vincristine in rats? Eur J Pain 2019;23:603-20. [PMID: 30376213 DOI: 10.1002/ejp.1333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Ortíz-Rentería M, Juárez-Contreras R, González-Ramírez R, Islas LD, Sierra-Ramírez F, Llorente I, Simon SA, Hiriart M, Rosenbaum T, Morales-Lázaro SL. TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain. Proc Natl Acad Sci U S A 2018;115:E1657-66. [PMID: 29378958 DOI: 10.1073/pnas.1715972115] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
44 Alon A, Schmidt H, Zheng S, Kruse AC. Structural Perspectives on Sigma-1 Receptor Function. Adv Exp Med Biol 2017;964:5-13. [PMID: 28315261 DOI: 10.1007/978-3-319-50174-1_2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
45 Yao H, Cai H, Li D. Thermostabilization of Membrane Proteins by Consensus Mutation: A Case Study for a Fungal Δ8-7 Sterol Isomerase. J Mol Biol 2020;432:5162-83. [PMID: 32105736 DOI: 10.1016/j.jmb.2020.02.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
46 Xu D, Wang J, Chen W, Yang X, Zhou J, Ma H, Di L, Duan J. Evaluation of analgesic and anti-inflammatory actions of indolealkylamines from toad venom in mice using lipidomics and molecular docking. J Ethnopharmacol 2021;269:113677. [PMID: 33321188 DOI: 10.1016/j.jep.2020.113677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Inserra A, De Gregorio D, Gobbi G. Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacol Rev 2021;73:202-77. [PMID: 33328244 DOI: 10.1124/pharmrev.120.000056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
48 Turnaturi R, Pasquinucci L, Chiechio S, Grasso M, Marrazzo A, Amata E, Dichiara M, Prezzavento O, Parenti C. Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist. ACS Chem Neurosci 2020;11:999-1005. [PMID: 32186844 DOI: 10.1021/acschemneuro.9b00688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
49 Shi JJ, Jiang QH, Zhang TN, Sun H, Shi WW, Gunosewoyo H, Yang F, Tang J, Pang T, Yu LF. Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia. Molecules 2021;26:1212. [PMID: 33668340 DOI: 10.3390/molecules26051212] [Reference Citation Analysis]
50 Amata E, Rescifina A, Prezzavento O, Arena E, Dichiara M, Pittalà V, Montilla-García Á, Punzo F, Merino P, Cobos EJ, Marrazzo A. (+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties. J Med Chem 2018;61:372-84. [PMID: 29220177 DOI: 10.1021/acs.jmedchem.7b01584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
51 Cao X, Yao Z, Dou F, Zhang Y, Qiu Y, Zhao S, Xu X, Liu X, Liu B, Chen Y, Zhang G. Synthesis and Biological Evaluation of Sigma‐1 (σ 1 ) Receptor Ligands Based on Phenyl‐1,2,4‐oxadiazole Derivatives. C&B 2019;16:e1800599. [DOI: 10.1002/cbdv.201800599] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
52 Laborenz J, Bykov YS, Knöringer K, Räschle M, Filker S, Prescianotto-Baschong C, Spang A, Tatsuta T, Langer T, Storchová Z, Schuldiner M, Herrmann JM. The ER protein Ema19 facilitates the degradation of nonimported mitochondrial precursor proteins. Mol Biol Cell 2021;32:664-74. [PMID: 33596095 DOI: 10.1091/mbc.E20-11-0748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
53 Tanaka S, Yoshinaka S, Kawamura K, Morita M, Kitamura M. Systematic asymmetric analog synthesis of fluspidine, a σ1 receptor ligand, to improve ligand affinity. Tetrahedron Letters 2021;85:153250. [DOI: 10.1016/j.tetlet.2021.153250] [Reference Citation Analysis]
54 Alon A, Lyu J, Braz JM, Tummino TA, Craik V, O'Meara MJ, Webb CM, Radchenko DS, Moroz YS, Huang XP, Liu Y, Roth BL, Irwin JJ, Basbaum AI, Shoichet BK, Kruse AC. Structures of the σ2 receptor enable docking for bioactive ligand discovery. Nature 2021;600:759-64. [PMID: 34880501 DOI: 10.1038/s41586-021-04175-x] [Reference Citation Analysis]
55 Reznikov LR, Norris MH, Vashisht R, Bluhm AP, Li D, Liao YJ, Brown A, Butte AJ, Ostrov DA. Identification of antiviral antihistamines for COVID-19 repurposing. Biochem Biophys Res Commun 2021;538:173-9. [PMID: 33309272 DOI: 10.1016/j.bbrc.2020.11.095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
56 Fernández-Dueñas V, Burgueño J, Ciruela F. Exploring Drug-Receptor Interaction Kinetics: Lessons from a Sigma-1 Receptor Transmembrane Biosensor. Front Pharmacol 2017;8:4. [PMID: 28144220 DOI: 10.3389/fphar.2017.00004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Oyer HM, Sanders CM, Kim FJ. Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes. Front Pharmacol 2019;10:1141. [PMID: 31695608 DOI: 10.3389/fphar.2019.01141] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
58 Mavlyutov TA, Duellman T, Kim HT, Epstein ML, Leese C, Davletov BA, Yang J. Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody. Neuroscience 2016;331:148-57. [PMID: 27339730 DOI: 10.1016/j.neuroscience.2016.06.030] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
59 Barwick SR, Siddiq MS, Wang J, Xiao H, Marshall B, Perry E, Smith SB. Sigma 1 Receptor Co-Localizes with NRF2 in Retinal Photoreceptor Cells. Antioxidants (Basel) 2021;10:981. [PMID: 34205384 DOI: 10.3390/antiox10060981] [Reference Citation Analysis]
60 Ehsan M, Du Y, Molist I, Seven AB, Hariharan P, Mortensen JS, Ghani L, Loland CJ, Skiniotis G, Guan L, Byrne B, Kobilka BK, Chae PS. Vitamin E-based glycoside amphiphiles for membrane protein structural studies. Org Biomol Chem 2018;16:2489-98. [PMID: 29564464 DOI: 10.1039/C8OB00270C] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
61 Prasanth MI, Malar DS, Tencomnao T, Brimson JM. The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer's. Expert Opin Ther Targets 2021;25:401-14. [PMID: 34110944 DOI: 10.1080/14728222.2021.1939681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
62 Bergkemper M, Kronenberg E, Thum S, Börgel F, Daniliuc C, Schepmann D, Nieto FR, Brust P, Reinoso RF, Alvarez I, Wünsch B. Synthesis, Receptor Affinity, and Antiallodynic Activity of Spirocyclic σ Receptor Ligands with Exocyclic Amino Moiety. J Med Chem 2018;61:9666-90. [PMID: 30350997 DOI: 10.1021/acs.jmedchem.8b01183] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
63 Rossino G, Orellana I, Caballero J, Schepmann D, Wünsch B, Rui M, Rossi D, González-avendaño M, Collina S, Vergara-jaque A. New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative. J Chem Inf Model 2020;60:756-65. [DOI: 10.1021/acs.jcim.9b00649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
64 Delprat B, Crouzier L, Su TP, Maurice T. At the Crossing of ER Stress and MAMs: A Key Role of Sigma-1 Receptor? Adv Exp Med Biol 2020;1131:699-718. [PMID: 31646531 DOI: 10.1007/978-3-030-12457-1_28] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
65 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Moreno E, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Blair RV, Roy CJ, Smith N, Hall JM, Tomera KM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Front Pharmacol 2021;12:633680. [PMID: 33833683 DOI: 10.3389/fphar.2021.633680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
66 Schepmann D, Neue C, Westphälinger S, Müller C, Bracher F, Lange C, Bednarski P, Almansa C, Friedland K, Räbiger V, Düfer M, Wünsch B. Pharmacological characterization of high-affinity σ1 receptor ligands with spirocyclic thienopyran and thienofuran scaffold. Journal of Pharmacy and Pharmacology 2020;72:236-48. [DOI: 10.1111/jphp.13196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
67 Bhandare RR, Sigalapalli DK, Shaik AB, Canney DJ, Blass BE. Selectivity profile comparison for certain γ-butyrolactone and oxazolidinone-based ligands on a sigma 2 receptor over sigma 1: a molecular docking approach. RSC Adv 2022;12:20096-109. [DOI: 10.1039/d2ra03497b] [Reference Citation Analysis]
68 Farran B. An update on the physiological and therapeutic relevance of GPCR oligomers. Pharmacol Res 2017;117:303-27. [PMID: 28087443 DOI: 10.1016/j.phrs.2017.01.008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 13.2] [Reference Citation Analysis]
69 Lipiński PFJ, Szűcs E, Jarończyk M, Kosson P, Benyhe S, Misicka A, Dobrowolski JC, Sadlej J. Affinity of fentanyl and its derivatives for the σ1-receptor. Medchemcomm 2019;10:1187-91. [PMID: 31391893 DOI: 10.1039/c9md00222g] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
70 Quadir SG, Cottone P, Sabino V. Role of Sigma Receptors in Alcohol Addiction. Front Pharmacol 2019;10:687. [PMID: 31258483 DOI: 10.3389/fphar.2019.00687] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
71 Prezzavento O, Arena E, Sánchez-Fernández C, Turnaturi R, Parenti C, Marrazzo A, Catalano R, Amata E, Pasquinucci L, Cobos EJ. (+)-and (-)-Phenazocine enantiomers: Evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects. Eur J Med Chem 2017;125:603-10. [PMID: 27721146 DOI: 10.1016/j.ejmech.2016.09.077] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
72 Amata E, Dichiara M, Gentile D, Marrazzo A, Turnaturi R, Arena E, La Mantia A, Tomasello BR, Acquaviva R, Di Giacomo C, Rescifina A, Prezzavento O. Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation. ACS Med Chem Lett 2020;11:889-94. [PMID: 32435401 DOI: 10.1021/acsmedchemlett.9b00661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
73 Alamri MA, Afzal O, Alamri MA. Computational screening of natural and natural-like compounds to identify novel ligands for sigma-2 receptor. SAR QSAR Environ Res 2020;31:837-56. [PMID: 33100033 DOI: 10.1080/1062936X.2020.1819870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Ehsan M, Ghani L, Du Y, Hariharan P, Mortensen JS, Ribeiro O, Hu H, Skiniotis G, Loland CJ, Guan L, Kobilka BK, Byrne B, Chae PS. New penta-saccharide-bearing tripod amphiphiles for membrane protein structure studies. Analyst 2017;142:3889-98. [PMID: 28913526 DOI: 10.1039/c7an01168g] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
75 Yano H, Bonifazi A, Xu M, Guthrie DA, Schneck SN, Abramyan AM, Fant AD, Hong WC, Newman AH, Shi L. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays. Neuropharmacology 2018;133:264-75. [PMID: 29407216 DOI: 10.1016/j.neuropharm.2018.01.042] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
76 Battista T, Pascarella G, Staid DS, Colotti G, Rosati J, Fiorillo A, Casamassa A, Vescovi AL, Giabbai B, Semrau MS, Fanelli S, Storici P, Squitieri F, Morea V, Ilari A. Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells. Int J Mol Sci 2021;22:1293. [PMID: 33525510 DOI: 10.3390/ijms22031293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Susa KJ, Seegar TC, Blacklow SC, Kruse AC. A dynamic interaction between CD19 and the tetraspanin CD81 controls B cell co-receptor trafficking. Elife 2020;9:e52337. [PMID: 32338599 DOI: 10.7554/eLife.52337] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
78 Morales-Lázaro SL, González-Ramírez R, Rosenbaum T. Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels. Front Pharmacol 2019;10:419. [PMID: 31068816 DOI: 10.3389/fphar.2019.00419] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
79 Espinosa-Juárez JV, Jaramillo-Morales OA, Navarrete-Vázquez G, Melo-Hernández LA, Déciga-Campos M, López-Muñoz FJ. N-(2-morpholin-4-yl-ethyl)-2-(1naphthyloxy)acetamide inhibits the chronic constriction injury-generated hyperalgesia via the antagonism of sigma-1 receptors. Eur J Pharmacol 2017;812:1-8. [PMID: 28648406 DOI: 10.1016/j.ejphar.2017.06.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
80 Shenkman M, Geva M, Gershoni-Emek N, Hayden MR, Lederkremer GZ. Pridopidine reduces mutant huntingtin-induced endoplasmic reticulum stress by modulation of the Sigma-1 receptor. J Neurochem 2021;158:467-81. [PMID: 33871049 DOI: 10.1111/jnc.15366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Abatematteo FS, Mosier PD, Niso M, Brunetti L, Berardi F, Loiodice F, Contino M, Delprat B, Maurice T, Laghezza A, Abate C. Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect. Eur J Med Chem 2022;228:114038. [PMID: 34902734 DOI: 10.1016/j.ejmech.2021.114038] [Reference Citation Analysis]
82 Amata E, Dichiara M, Arena E, Pittalà V, Pistarà V, Cardile V, Graziano ACE, Fraix A, Marrazzo A, Sortino S, Prezzavento O. Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect. J Med Chem 2017;60:9531-44. [PMID: 29172528 DOI: 10.1021/acs.jmedchem.7b00791] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
83 Watanabe S, Ilieva H, Tamada H, Nomura H, Komine O, Endo F, Jin S, Mancias P, Kiyama H, Yamanaka K. Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol Med 2016;8:1421-37. [PMID: 27821430 DOI: 10.15252/emmm.201606403] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 18.8] [Reference Citation Analysis]
84 Walby GD, Martin SF. Preparation of novel analogs of 2-arylpiperidines and evaluation of their sigma receptor binding affinities. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114310] [Reference Citation Analysis]
85 Bae HE, Cecchetti C, Du Y, Katsube S, Mortensen JS, Huang W, Rehan S, Lee HJ, Loland CJ, Guan L, Kobilka BK, Byrne B, Chae PS. Pendant-bearing glucose-neopentyl glycol (P-GNG) amphiphiles for membrane protein manipulation: Importance of detergent pendant chain for protein stabilization. Acta Biomater 2020;112:250-61. [PMID: 32522715 DOI: 10.1016/j.actbio.2020.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
86 Pasternak GW. Allosteric Modulation of Opioid G-Protein Coupled Receptors by Sigma1 Receptors. In: Kim FJ, Pasternak GW, editors. Sigma Proteins: Evolution of the Concept of Sigma Receptors. Cham: Springer International Publishing; 2017. pp. 163-75. [DOI: 10.1007/164_2017_34] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
87 Del Bello F, Micioni Di Bonaventura MV, Bonifazi A, Wünsch B, Schepmann D, Giancola JB, Micioni Di Bonaventura E, Vistoli G, Giorgioni G, Quaglia W, Piergentili A, Cifani C. Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane. ACS Chem Neurosci 2019;10:3391-7. [PMID: 31298830 DOI: 10.1021/acschemneuro.9b00261] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
88 Xu L, Chen LY. Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions. Chem Biol Drug Des 2021;97:1194-209. [PMID: 33754484 DOI: 10.1111/cbdd.13841] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Derouiche L, Massotte D. G protein-coupled receptor heteromers are key players in substance use disorder. Neurosci Biobehav Rev 2019;106:73-90. [PMID: 30278192 DOI: 10.1016/j.neubiorev.2018.09.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
90 Dreser A, Vollrath JT, Sechi A, Johann S, Roos A, Yamoah A, Katona I, Bohlega S, Wiemuth D, Tian Y, Schmidt A, Vervoorts J, Dohmen M, Beyer C, Anink J, Aronica E, Troost D, Weis J, Goswami A. The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ 2017;24:1655-71. [PMID: 28622300 DOI: 10.1038/cdd.2017.88] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
91 Ehsan M, Du Y, Mortensen JS, Hariharan P, Qu Q, Ghani L, Das M, Grethen A, Byrne B, Skiniotis G, Keller S, Loland CJ, Guan L, Kobilka BK, Chae PS. Self-Assembly Behavior and Application of Terphenyl-Cored Trimaltosides for Membrane-Protein Studies: Impact of Detergent Hydrophobic Group Geometry on Protein Stability. Chemistry 2019;25:11545-54. [PMID: 31243822 DOI: 10.1002/chem.201902468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
92 Wheeler MA, Jaronen M, Covacu R, Zandee SEJ, Scalisi G, Rothhammer V, Tjon EC, Chao CC, Kenison JE, Blain M, Rao VTS, Hewson P, Barroso A, Gutiérrez-Vázquez C, Prat A, Antel JP, Hauser R, Quintana FJ. Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation. Cell 2019;176:581-596.e18. [PMID: 30661753 DOI: 10.1016/j.cell.2018.12.012] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 17.0] [Reference Citation Analysis]
93 Casanovas M, Jiménez-Rosés M, Cordomí A, Lillo A, Vega-Quiroga I, Izquierdo J, Medrano M, Gysling K, Pardo L, Navarro G, Franco R. Discovery of a macromolecular complex mediating the hunger suppressive actions of cocaine: Structural and functional properties. Addict Biol 2021;26:e13017. [PMID: 33559278 DOI: 10.1111/adb.13017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Aguinaga D, Medrano M, Vega-Quiroga I, Gysling K, Canela EI, Navarro G, Franco R. Cocaine Effects on Dopaminergic Transmission Depend on a Balance between Sigma-1 and Sigma-2 Receptor Expression. Front Mol Neurosci 2018;11:17. [PMID: 29483862 DOI: 10.3389/fnmol.2018.00017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
95 Schinor B, Hruschka S, Daniliuc CG, Schepmann D, Wünsch B, Haufe G. Fluorinated 2-Arylcyclopropan-1-amines - A new class of sigma receptor ligands. Bioorg Med Chem 2020;28:115726. [PMID: 33007549 DOI: 10.1016/j.bmc.2020.115726] [Reference Citation Analysis]
96 Iyamu ID, Lv W, Malik N, Mishra RK, Schiltz GE. Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands. Bioorg Med Chem 2019;27:1824-35. [PMID: 30904383 DOI: 10.1016/j.bmc.2019.03.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Abramyan AM, Yano H, Xu M, Liu L, Naing S, Fant AD, Shi L. The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor. Comput Struct Biotechnol J 2020;18:199-206. [PMID: 32055286 DOI: 10.1016/j.csbj.2019.12.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
98 Noyer L, Lemonnier L, Mariot P, Gkika D. Partners in Crime: Towards New Ways of Targeting Calcium Channels. Int J Mol Sci 2019;20:E6344. [PMID: 31888223 DOI: 10.3390/ijms20246344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
99 Jabłońska M, Grzelakowska K, Wiśniewski B, Mazur E, Leis K, Gałązka P. Pridopidine in the treatment of Huntington's disease. Rev Neurosci 2020;31:441-51. [PMID: 32083454 DOI: 10.1515/revneuro-2019-0085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Lever JR, Fergason-cantrell EA. Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax). Pharmacological Research 2019;142:87-100. [DOI: 10.1016/j.phrs.2019.01.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
101 Frontera A, Bauzá A. Biological halogen bonds in protein-ligand complexes: a combined QTAIM and NCIPlot study in four representative cases. Org Biomol Chem 2021;19:6858-64. [PMID: 34319314 DOI: 10.1039/d1ob01212f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
102 Zhemkov V, Geva M, Hayden MR, Bezprozvanny I. Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases. Int J Mol Sci 2021;22:4082. [PMID: 33920913 DOI: 10.3390/ijms22084082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Weng TY, Hung DT, Su TP, Tsai SA. Loss of Sigma-1 Receptor Chaperone Promotes Astrocytosis and Enhances the Nrf2 Antioxidant Defense. Oxid Med Cell Longev 2017;2017:4582135. [PMID: 28883901 DOI: 10.1155/2017/4582135] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
104 Porter MR, Xiao H, Maity S, Vail N, Smith SB, Topczewski JJ. Enhanced Affinity for 3-Amino-Chromane-Derived σ1 Receptor Ligands. ACS Omega 2020;5:32724-37. [PMID: 33376910 DOI: 10.1021/acsomega.0c05117] [Reference Citation Analysis]
105 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Olmo EMD, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Smith N, Hall JM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Res Sq 2020:rs. [PMID: 32702719 DOI: 10.21203/rs.3.rs-30934/v2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
106 Ryskamp D, Wu L, Wu J, Kim D, Rammes G, Geva M, Hayden M, Bezprozvanny I. Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor. Neurobiol Dis 2019;124:489-504. [PMID: 30594810 DOI: 10.1016/j.nbd.2018.12.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
107 Ma MT, Chen DH, Raskind WH, Bird TD. Mutations in the SIGMAR1 gene cause a distal hereditary motor neuropathy phenotype mimicking ALS: Report of two novel variants. Neuromuscul Disord 2020;30:572-5. [PMID: 32600828 DOI: 10.1016/j.nmd.2020.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Ehsan M, Katsube S, Cecchetti C, Du Y, Mortensen JS, Wang H, Nygaard A, Ghani L, Loland CJ, Kobilka BK, Byrne B, Guan L, Chae PS. New Malonate-Derived Tetraglucoside Detergents for Membrane Protein Stability. ACS Chem Biol 2020;15:1697-707. [PMID: 32501004 DOI: 10.1021/acschembio.0c00316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Torres-Gómez H, Daniliuc C, Schepmann D, Laurini E, Pricl S, Wünsch B. Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ Affinity. Int J Mol Sci 2021;22:5685. [PMID: 34073622 DOI: 10.3390/ijms22115685] [Reference Citation Analysis]
110 Huang L, Xiao H, Xie X, Hu F, Tang F, Smith SB, Gan L. Generation of Sigmar1 conditional knockout mouse using CRISPR-Cas9 gene targeting. Genesis 2022;:e23487. [PMID: 35633570 DOI: 10.1002/dvg.23487] [Reference Citation Analysis]
111 Longhitano L, Castracani CC, Tibullo D, Avola R, Viola M, Russo G, Prezzavento O, Marrazzo A, Amata E, Reibaldi M, Longo A, Russo A, Parrinello NL, Volti GL. Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma. Oncotarget 2017;8:91099-111. [PMID: 29207628 DOI: 10.18632/oncotarget.19556] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
112 Rossino G, Rui M, Pozzetti L, Schepmann D, Wünsch B, Zampieri D, Pellavio G, Laforenza U, Rinaldi S, Colombo G, Morelli L, Linciano P, Rossi D, Collina S. Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R). Int J Mol Sci 2020;21:E7708. [PMID: 33081037 DOI: 10.3390/ijms21207708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 Abdullah CS, Alam S, Aishwarya R, Miriyala S, Panchatcharam M, Bhuiyan MAN, Peretik JM, Orr AW, James J, Osinska H, Robbins J, Lorenz JN, Bhuiyan MS. Cardiac Dysfunction in the Sigma 1 Receptor Knockout Mouse Associated With Impaired Mitochondrial Dynamics and Bioenergetics. J Am Heart Assoc 2018;7:e009775. [PMID: 30371279 DOI: 10.1161/JAHA.118.009775] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
114 Yang H, Shen H, Li J, Stanford KI, Guo LW. Sigma-1 receptor ablation impedes adipocyte-like differentiation of mouse embryonic fibroblasts. Cell Signal 2020;75:109732. [PMID: 32750415 DOI: 10.1016/j.cellsig.2020.109732] [Reference Citation Analysis]
115 Floresta G, Dichiara M, Gentile D, Prezzavento O, Marrazzo A, Rescifina A, Amata E. Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands. Int J Mol Sci 2019;20:E488. [PMID: 30678129 DOI: 10.3390/ijms20030488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
116 Shi D, Chahal KK, Oto P, Nothias LF, Debnath A, McKerrow JH, Podust LM, Abagyan R. Identification of Four Amoebicidal Nontoxic Compounds by a Molecular Docking Screen of Naegleria fowleri Sterol Δ8-Δ7-Isomerase and Phenotypic Assays. ACS Infect Dis 2019;5:2029-38. [PMID: 31583882 DOI: 10.1021/acsinfecdis.9b00227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
117 Soriani O, Kourrich S. The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer. Front Neurosci 2019;13:1186. [PMID: 31780884 DOI: 10.3389/fnins.2019.01186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
118 Fallica AN, Pittalà V, Modica MN, Salerno L, Romeo G, Marrazzo A, Helal MA, Intagliata S. Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective. J Med Chem 2021;64:7926-62. [PMID: 34076441 DOI: 10.1021/acs.jmedchem.0c02265] [Reference Citation Analysis]
119 [DOI: 10.1101/699793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Zhao L, Chen G, Li J, Fu Y, Mavlyutov TA, Yao A, Nickells RW, Gong S, Guo LW. An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration. J Control Release 2017;247:153-66. [PMID: 28063892 DOI: 10.1016/j.jconrel.2016.12.038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
121 Niso M, Mosier PD, Marottoli R, Ferorelli S, Cassano G, Gasparre G, Leopoldo M, Berardi F, Abate C. High-affinity sigma-1 (σ1) receptor ligands based on the σ1 antagonist PB212. Future Med Chem 2019;11:2547-62. [PMID: 31633399 DOI: 10.4155/fmc-2019-0042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
122 Shi JJ, Jia KH, Sun H, Gunosewoyo H, Yang F, Tang J, Luo J, Yu LF. Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma. ChemMedChem 2021;16:524-36. [PMID: 32964625 DOI: 10.1002/cmdc.202000461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Blass BE, Gao R, Blattner KM, Gordon JC, Pippin DA, Canney DJ. Synthesis and evaluation of novel, selective, functionalized γ-butyrolactones as sigma-2 ligands. Med Chem Res 2022;31:337-49. [DOI: 10.1007/s00044-021-02831-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Blass BE, Bhandare RR, Canney DJ. Discovery of oxazolidinone-based heterocycles as subtype selective sigma-2 ligands. Med Chem Res. [DOI: 10.1007/s00044-022-02848-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Vavers E, Zvejniece L, Maurice T, Dambrova M. Allosteric Modulators of Sigma-1 Receptor: A Review. Front Pharmacol 2019;10:223. [PMID: 30941035 DOI: 10.3389/fphar.2019.00223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
126 Higgins MK, Lea SM. On the state of crystallography at the dawn of the electron microscopy revolution. Curr Opin Struct Biol 2017;46:95-101. [PMID: 28686957 DOI: 10.1016/j.sbi.2017.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
127 Collina S, Bignardi E, Rui M, Rossi D, Gaggeri R, Zamagni A, Cortesi M, Tesei A. Are sigma modulators an effective opportunity for cancer treatment? A patent overview (1996-2016). Expert Opin Ther Pat 2017;27:565-78. [PMID: 28051882 DOI: 10.1080/13543776.2017.1276569] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
128 Wei X, Zheng Z, Feng Z, Zheng L, Tao S, Zheng B, Huang B, Zhang X, Liu J, Chen Y, Zong W, Shan Z, Fan S, Chen J, Zhao F. Sigma-1 receptor attenuates osteoclastogenesis by promoting ER-associated degradation of SERCA2. EMBO Mol Med 2022;:e15373. [PMID: 35611810 DOI: 10.15252/emmm.202115373] [Reference Citation Analysis]
129 Wang SM, Wu HE, Yasui Y, Geva M, Hayden M, Maurice T, Cozzolino M, Su TP. Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine. Autophagy 2022;:1-26. [PMID: 35507432 DOI: 10.1080/15548627.2022.2063003] [Reference Citation Analysis]
130 Voronin MV, Vakhitova YV, Tsypysheva IP, Tsypyshev DO, Rybina IV, Kurbanov RD, Abramova EV, Seredenin SB. Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole. Int J Mol Sci 2021;22:5455. [PMID: 34064275 DOI: 10.3390/ijms22115455] [Reference Citation Analysis]
131 Blass BE, Gao R, Blattner KM, Gordon JC, Pippin DA, Canney DJ. Design, synthesis, and evaluation of novel, selective γ-butyrolactones sigma-2 ligands. Med Chem Res 2021;30:1713-27. [DOI: 10.1007/s00044-021-02771-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Hussain H, Helton T, Du Y, Mortensen JS, Hariharan P, Ehsan M, Byrne B, Loland CJ, Kobilka BK, Guan L, Chae PS. A comparative study of branched and linear mannitol-based amphiphiles on membrane protein stability. Analyst 2018;143:5702-10. [PMID: 30334564 DOI: 10.1039/c8an01408f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
133 Yang H, Fu Y, Liu X, Shahi PK, Mavlyutov TA, Li J, Yao A, Guo SZ, Pattnaik BR, Guo LW. Role of the sigma-1 receptor chaperone in rod and cone photoreceptor degenerations in a mouse model of retinitis pigmentosa. Mol Neurodegener 2017;12:68. [PMID: 28927431 DOI: 10.1186/s13024-017-0202-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
134 Long T, Hassan A, Thompson BM, McDonald JG, Wang J, Li X. Structural basis for human sterol isomerase in cholesterol biosynthesis and multidrug recognition. Nat Commun 2019;10:2452. [PMID: 31165728 DOI: 10.1038/s41467-019-10279-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
135 Intagliata S, Sharma A, King TI, Mesangeau C, Seminerio M, Chin FT, Wilson LL, Matsumoto RR, McLaughlin JP, Avery BA, McCurdy CR. Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo. AAPS J 2020;22:94. [PMID: 32691179 DOI: 10.1208/s12248-020-00472-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
136 Ehsan M, Wang H, Cecchetti C, Mortensen JS, Du Y, Hariharan P, Nygaard A, Lee HJ, Ghani L, Guan L, Loland CJ, Byrne B, Kobilka BK, Chae PS. Maltose-bis(hydroxymethyl)phenol (MBPs) and Maltose-tris(hydroxymethyl)phenol (MTPs) Amphiphiles for Membrane Protein Stability. ACS Chem Biol 2021;16:1779-90. [PMID: 34445864 DOI: 10.1021/acschembio.1c00578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
137 Kronenberg E, Weber F, Schepmann D, Wünsch B. Synthesis and σ receptor affinity of spiro[[2]benzopyran-1,1'-cyclohexanes] with an exocyclic amino moiety in the 3'-position. RSC Med Chem 2021;12:237-44. [PMID: 34046612 DOI: 10.1039/d0md00307g] [Reference Citation Analysis]
138 Motawe ZY, Abdelmaboud SS, Cuevas J, Breslin JW. PRE-084 as a tool to uncover potential therapeutic applications for selective sigma-1 receptor activation. Int J Biochem Cell Biol 2020;126:105803. [PMID: 32668330 DOI: 10.1016/j.biocel.2020.105803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
139 Kim FJ, Pasternak GW. σ1 Receptor ligand binding: an open-and-shut case. Nat Struct Mol Biol 2018;25:992-3. [PMID: 30310147 DOI: 10.1038/s41594-018-0146-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
140 Blass BE, Blattner KM, Gordon JC, Elokely KM, Pippin DA, Canney DJ. Discovery of novel, selective, functionalized 5-(2-(5-arylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)ethyl)-γ-butyrolactone sigma-2 ligands. Med Chem Res. [DOI: 10.1007/s00044-022-02909-8] [Reference Citation Analysis]
141 Alamri MA, Alamri MA. Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands. Bioinformation 2019;15:586-95. [PMID: 31719769 DOI: 10.6026/97320630015586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
142 Díaz JL, Cuevas F, Oliva AI, Font D, Sarmentero MÁ, Álvarez-Bercedo P, López-Valbuena JM, Pericàs MA, Enrech R, Montero A, Yeste S, Vidal-Torres A, Álvarez I, Pérez P, Cendán CM, Cobos EJ, Vela JM, Almansa C. Tricyclic Triazoles as σ1 Receptor Antagonists for Treating Pain. J Med Chem 2021;64:5157-70. [PMID: 33826322 DOI: 10.1021/acs.jmedchem.1c00244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Kruse A. Structural Insights into Sigma1 Function. Handb Exp Pharmacol 2017;244:13-25. [PMID: 27995388 DOI: 10.1007/164_2016_95] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
144 Maurice T, Goguadze N. Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases. Handb Exp Pharmacol 2017;244:81-108. [PMID: 28275911 DOI: 10.1007/164_2017_15] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
145 Dvorácskó S, Lázár L, Fülöp F, Palkó M, Zalán Z, Penke B, Fülöp L, Tömböly C, Bogár F. Novel High Affinity Sigma-1 Receptor Ligands from Minimal Ensemble Docking-Based Virtual Screening. Int J Mol Sci 2021;22:8112. [PMID: 34360878 DOI: 10.3390/ijms22158112] [Reference Citation Analysis]
146 Ossa F, Schnell JR, Ortega-Roldan JL. A Review of the Human Sigma-1 Receptor Structure. Adv Exp Med Biol 2017;964:15-29. [PMID: 28315262 DOI: 10.1007/978-3-319-50174-1_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
147 Kim FJ, Maher CM. Sigma1 Pharmacology in the Context of Cancer. Handb Exp Pharmacol 2017;244:237-308. [PMID: 28744586 DOI: 10.1007/164_2017_38] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
148 Thum S, Schepmann D, Ayet E, Pujol M, Nieto FR, Ametamey SM, Wünsch B. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ1 receptor antagonists: Synthesis, receptor affinity, selectivity and antiallodynic activity. European Journal of Medicinal Chemistry 2019;177:47-62. [DOI: 10.1016/j.ejmech.2019.05.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
149 Floresta G, Rescifina A, Marrazzo A, Dichiara M, Pistarà V, Pittalà V, Prezzavento O, Amata E. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands. Eur J Med Chem 2017;139:884-91. [PMID: 28866257 DOI: 10.1016/j.ejmech.2017.08.053] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
150 Yang H, Shen H, Li J, Guo LW. SIGMAR1/Sigma-1 receptor ablation impairs autophagosome clearance. Autophagy 2019;15:1539-57. [PMID: 30871407 DOI: 10.1080/15548627.2019.1586248] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
151 Prasanna X, Salo VT, Li S, Ven K, Vihinen H, Jokitalo E, Vattulainen I, Ikonen E. Seipin traps triacylglycerols to facilitate their nanoscale clustering in the endoplasmic reticulum membrane. PLoS Biol 2021;19:e3000998. [PMID: 33481779 DOI: 10.1371/journal.pbio.3000998] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
152 Mavlyutov TA, Yang H, Epstein ML, Ruoho AE, Yang J, Guo LW. APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. Oncotarget 2017;8:51317-30. [PMID: 28881650 DOI: 10.18632/oncotarget.17906] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
153 Stracina T, Novakova M. Cardiac sigma receptors - an update. Physiol Res 2018;67:S561-76. [PMID: 30607964 DOI: 10.33549/physiolres.934052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
154 Franchini S, Sorbi C, Battisti UM, Tait A, Bencheva LI, Cichero E, Fossa P, Cilia A, Prezzavento O, Ronsisvalle S, Aricò G, Benassi L, Vaschieri C, Azzoni P, Magnoni C, Brasili L. Structure-Activity Relationships within a Series of σ 1 and σ 2 Receptor Ligands: Identification of a σ 2 Receptor Agonist (BS148) with Selective Toxicity against Metastatic Melanoma. ChemMedChem 2017;12:1893-905. [DOI: 10.1002/cmdc.201700427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
155 Yi B, Sahn JJ, Ardestani PM, Evans AK, Scott LL, Chan JZ, Iyer S, Crisp A, Zuniga G, Pierce JT, Martin SF, Shamloo M. Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease. J Neurochem 2017;140:561-75. [PMID: 27926996 DOI: 10.1111/jnc.13917] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 11.2] [Reference Citation Analysis]
156 Riad A, Zeng C, Weng CC, Winters H, Xu K, Makvandi M, Metz T, Carlin S, Mach RH. Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex. Sci Rep 2018;8:16845. [PMID: 30443021 DOI: 10.1038/s41598-018-35430-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 13.3] [Reference Citation Analysis]
157 Weng TY, Tsai SA, Su TP. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases. J Biomed Sci 2017;24:74. [PMID: 28917260 DOI: 10.1186/s12929-017-0380-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
158 Lasitza-Male T, Bartels K, Jungwirth J, Wiggers F, Rosenblum G, Hofmann H, Löw C. Membrane Chemistry Tunes the Structure of a Peptide Transporter. Angew Chem Int Ed Engl 2020;59:19121-8. [PMID: 32744783 DOI: 10.1002/anie.202008226] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
159 Smith SB. Introduction to Sigma Receptors: Their Role in Disease and as Therapeutic Targets. In: Smith SB, Su T, editors. Sigma Receptors: Their Role in Disease and as Therapeutic Targets. Cham: Springer International Publishing; 2017. pp. 1-4. [DOI: 10.1007/978-3-319-50174-1_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
160 Mavlyutov TA, Baker EM, Losenegger TM, Kim JR, Torres B, Epstein ML, Ruoho AE. The Sigma-1 Receptor-A Therapeutic Target for the Treatment of ALS? Adv Exp Med Biol 2017;964:255-65. [PMID: 28315276 DOI: 10.1007/978-3-319-50174-1_17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
161 Perez-Dominguez F, Carrillo-Beltrán D, Blanco R, Muñoz JP, León-Cruz G, Corvalan AH, Urzúa U, Calaf GM, Aguayo F. Role of Pirin, an Oxidative Stress Sensor Protein, in Epithelial Carcinogenesis. Biology (Basel) 2021;10:116. [PMID: 33557375 DOI: 10.3390/biology10020116] [Reference Citation Analysis]
162 Kurciński M, Jarończyk M, Lipiński PFJ, Dobrowolski JC, Sadlej J. Structural Insights into σ₁ Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations. Molecules 2018;23:E456. [PMID: 29463040 DOI: 10.3390/molecules23020456] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
163 Déciga-Campos M, Melo-Hernández LA, Torres-Gómez H, Wünsch B, Schepmann D, González-Trujano ME, Espinosa-Juárez J, López-Muñoz FJ, Navarrete-Vázquez G. Design and synthesis of N‑(benzylpiperidinyl)‑4‑fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ1 receptor antagonism. Life Sci 2020;245:117348. [PMID: 31981633 DOI: 10.1016/j.lfs.2020.117348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Chipot C, Dehez F, Schnell JR, Zitzmann N, Pebay-Peyroula E, Catoire LJ, Miroux B, Kunji ERS, Veglia G, Cross TA, Schanda P. Perturbations of Native Membrane Protein Structure in Alkyl Phosphocholine Detergents: A Critical Assessment of NMR and Biophysical Studies. Chem Rev 2018;118:3559-607. [PMID: 29488756 DOI: 10.1021/acs.chemrev.7b00570] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 24.0] [Reference Citation Analysis]
165 Youssef E, El-moneim MA, Fathalla W, Nafie MS. Design, synthesis and antiproliferative activity of new amine, amino acid and dipeptide-coupled benzamides as potential sigma-1 receptor. J IRAN CHEM SOC 2020;17:2515-32. [DOI: 10.1007/s13738-020-01947-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
166 Wong AYC, Hristova E, Ahlskog N, Tasse L, Ngsee JK, Chudalayandi P, Bergeron R. Aberrant Subcellular Dynamics of Sigma-1 Receptor Mutants Underlying Neuromuscular Diseases. Mol Pharmacol 2016;90:238-53. [DOI: 10.1124/mol.116.104018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
167 Weber F, Wünsch B. Medicinal Chemistry of σ1 Receptor Ligands: Pharmacophore Models, Synthesis, Structure Affinity Relationships, and Pharmacological Applications. In: Kim FJ, Pasternak GW, editors. Sigma Proteins: Evolution of the Concept of Sigma Receptors. Cham: Springer International Publishing; 2017. pp. 51-79. [DOI: 10.1007/164_2017_33] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
168 Shinoda Y, Haga Y, Akagawa K, Fukunaga K. Wildtype σ1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity. J Biol Chem 2020;295:17573-87. [PMID: 33453999 DOI: 10.1074/jbc.RA120.015012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Al-Ghanim L, Zhu XY, Asong G, Ablordeppey SY. SYA 013 analogs as moderately selective sigma-2 (σ2) ligands: Structure-affinity relationship studies. Bioorg Med Chem 2019;27:2421-6. [PMID: 30737135 DOI: 10.1016/j.bmc.2019.01.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
170 Aguinaga D, Medrano M, Cordomí A, Jiménez-rosés M, Angelats E, Casanovas M, Vega-quiroga I, Canela EI, Petrovic M, Gysling K, Pardo L, Franco R, Navarro G. Cocaine Blocks Effects of Hunger Hormone, Ghrelin, Via Interaction with Neuronal Sigma-1 Receptors. Mol Neurobiol 2019;56:1196-210. [DOI: 10.1007/s12035-018-1140-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
171 Mcleod MC, Aubé J, Frankowski KJ. Decahydrobenzoquinolin-5-one sigma receptor ligands: Divergent development of both sigma 1 and sigma 2 receptor selective examples. Bioorganic & Medicinal Chemistry Letters 2016;26:5689-94. [DOI: 10.1016/j.bmcl.2016.10.065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
172 Kim FJ, Pasternak GW. Cloning the sigma2 receptor: Wandering 40 years to find an identity. Proc Natl Acad Sci U S A 2017;114:6888-90. [PMID: 28645899 DOI: 10.1073/pnas.1708155114] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
173 Ververis A, Dajani R, Koutsou P, Aloqaily A, Nelson-Williams C, Loring E, Arafat A, Mubaidin AF, Horany K, Bader MB, Al-Baho Y, Ali B, Muhtaseb A, DeSpenza T Jr, Al-Qudah AA, Middleton LT, Zamba-Papanicolaou E, Lifton R, Christodoulou K. Distal hereditary motor neuronopathy of the Jerash type is caused by a novel SIGMAR1 c.500A>T missense mutation. J Med Genet 2020;57:178-86. [PMID: 31511340 DOI: 10.1136/jmedgenet-2019-106108] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
174 Díaz JL, Corbera J, Martínez D, Bordas M, Sicre C, Pascual R, Pretel MJ, Marín AP, Montero A, Dordal A, Alvarez I, Almansa C. Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4. Medchemcomm 2017;8:1246-54. [PMID: 30108835 DOI: 10.1039/c7md00078b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
175 Rui M, Rossino G, Coniglio S, Monteleone S, Scuteri A, Malacrida A, Rossi D, Catenacci L, Sorrenti M, Paolillo M, Curti D, Venturini L, Schepmann D, Wünsch B, Liedl KR, Cavaletti G, Pace V, Urban E, Collina S. Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents. Eur J Med Chem 2018;158:353-70. [PMID: 30223122 DOI: 10.1016/j.ejmech.2018.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
176 Yang K, Wang C, Sun T. The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD). Front Pharmacol 2019;10:528. [PMID: 31178723 DOI: 10.3389/fphar.2019.00528] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
177 Alamri MA, Ates-Alagoz Z, Adejare A. Bicycloheptylamine-Doxorubicin Conjugate: Synthesis and Anticancer Activities in σ2 Receptor-Expressing Cell Lines. Med Chem 2020;16:192-201. [PMID: 30827254 DOI: 10.2174/1573406415666190301145203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
178 Vlainić J, Jović O, Kosalec I, Vugrek O, Čož-Rakovac R, Šmuc T. In Vitro Confirmation of Siramesine as a Novel Antifungal Agent with In Silico Lead Proposals of Structurally Related Antifungals. Molecules 2021;26:3504. [PMID: 34201401 DOI: 10.3390/molecules26123504] [Reference Citation Analysis]
179 Xie XY, Li YY, Ma WH, Chen AF, Sun YT, Lee JY, Riad A, Xu DH, Mach RH, Huang YS. Synthesis, binding, and functional properties of tetrahydroisoquinolino-2-alkyl phenones as selective σ2R/TMEM97 ligands. Eur J Med Chem 2021;209:112906. [PMID: 33049607 DOI: 10.1016/j.ejmech.2020.112906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
180 Elkholy N, Abdelwaly A, Mohamed K, Amata E, Lombino J, Cosentino G, Intagliata S, Helal MA. Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands. Chem Biol Drug Des 2022;100:25-40. [PMID: 35353926 DOI: 10.1111/cbdd.14047] [Reference Citation Analysis]
181 Vitale RM, Iannotti FA, Amodeo P. The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets. Int J Mol Sci 2021;22:4876. [PMID: 34062987 DOI: 10.3390/ijms22094876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
182 Lan Y, Bai P, Chen Z, Neelamegam R, Placzek MS, Wang H, Fiedler SA, Yang J, Yuan G, Qu X, Schmidt HR, Song J, Normandin MD, Ran C, Wang C. Novel radioligands for imaging sigma-1 receptor in brain using positron emission tomography (PET). Acta Pharm Sin B 2019;9:1204-15. [PMID: 31867166 DOI: 10.1016/j.apsb.2019.07.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
183 Niso M, Pati ML, Berardi F, Abate C. Rigid versus flexible anilines or anilides confirm the bicyclic ring as the hydrophobic portion for optimal σ 2 receptor binding and provide novel tools for the development of future σ 2 receptor PET radiotracers. RSC Adv 2016;6:88508-18. [DOI: 10.1039/c6ra15783a] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
184 Maurice T, Volle JN, Strehaiano M, Crouzier L, Pereira C, Kaloyanov N, Virieux D, Pirat JL. Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ1 receptors. Pharmacol Res 2019;144:315-30. [PMID: 31048034 DOI: 10.1016/j.phrs.2019.04.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
185 Collina S, Rui M, Stotani S, Bignardi E, Rossi D, Curti D, Giordanetto F, Malacrida A, Scuteri A, Cavaletti G. Are sigma receptor modulators a weapon against multiple sclerosis disease? Future Medicinal Chemistry 2017;9:2029-51. [DOI: 10.4155/fmc-2017-0122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
186 Abatematteo FS, Niso M, Lacivita E, Abate C. σ2 Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach. Molecules 2021;26:3743. [PMID: 34205334 DOI: 10.3390/molecules26123743] [Reference Citation Analysis]
187 Devadiga SJ, Bharate SS. Recent developments in the management of Huntington's disease. Bioorg Chem 2022;120:105642. [PMID: 35121553 DOI: 10.1016/j.bioorg.2022.105642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Gangangari KK, Váradi A, Majumdar S, Larson SM, Pasternak GW, Pillarsetty NK. Imaging Sigma-1 Receptor (S1R) Expression Using Iodine-124-Labeled 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine ([124I]IPAG). Mol Imaging Biol 2020;22:358-66. [PMID: 31165385 DOI: 10.1007/s11307-019-01369-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
189 Peng Y, Zhang Q, Welsh WJ. Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management. J Med Chem 2021;64:890-904. [PMID: 33372782 DOI: 10.1021/acs.jmedchem.0c01964] [Reference Citation Analysis]
190 Rossino G, Rui M, Linciano P, Rossi D, Boiocchi M, Peviani M, Poggio E, Curti D, Schepmann D, Wünsch B, González-Avendaño M, Vergara-Jaque A, Caballero J, Collina S. Bitopic Sigma 1 Receptor Modulators to Shed Light on Molecular Mechanisms Underpinning Ligand Binding and Receptor Oligomerization. J Med Chem 2021;64:14997-5016. [PMID: 34624193 DOI: 10.1021/acs.jmedchem.1c00886] [Reference Citation Analysis]
191 Kim FJ. Introduction to Sigma Proteins: Evolution of the Concept of Sigma Receptors. Handb Exp Pharmacol 2017;244:1-11. [PMID: 28871306 DOI: 10.1007/164_2017_41] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
192 Pereira AC, Madeira N, Morais S, Macedo A, Cruz MT, Pereira CMF. Mitochondria Fusion upon SERCA Inhibition Prevents Activation of the NLRP3 Inflammasome in Human Monocytes. Cells 2022;11:433. [DOI: 10.3390/cells11030433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Martin SF. Natural Products and Their Mimics as Targets of Opportunity for Discovery. J Org Chem 2017;82:10757-94. [PMID: 28738152 DOI: 10.1021/acs.joc.7b01368] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
194 Zhuang T, Xiong J, Ren X, Liang L, Qi Z, Zhang S, Du W, Chen Y, Liu X, Zhang G. Benzylaminofentanyl derivates: Discovery of bifunctional μ opioid and σ1 receptor ligands as novel analgesics with reduced adverse effects. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114649] [Reference Citation Analysis]
195 Benarroch EE. Sigma-1 receptor and amyotrophic lateral sclerosis. Neurology 2018;91:743-7. [PMID: 30242016 DOI: 10.1212/WNL.0000000000006347] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
196 Sambo DO, Lin M, Owens A, Lebowitz JJ, Richardson B, Jagnarine DA, Shetty M, Rodriquez M, Alonge T, Ali M, Katz J, Yan L, Febo M, Henry LK, Bruijnzeel AW, Daws L, Khoshbouei H. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat Commun 2017;8:2228. [PMID: 29263318 DOI: 10.1038/s41467-017-02087-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 9.6] [Reference Citation Analysis]
197 Romero L, Portillo-Salido E. Trends in Sigma-1 Receptor Research: A 25-Year Bibliometric Analysis. Front Pharmacol. 2019;10:564. [PMID: 31178733 DOI: 10.3389/fphar.2019.00564] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
198 Reyes-parada M, Iturriaga-vasquez P. The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors. Expert Opinion on Drug Discovery 2016;11:969-81. [DOI: 10.1080/17460441.2016.1227317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
199 Ryskamp D, Wu J, Geva M, Kusko R, Grossman I, Hayden M, Bezprozvanny I. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease. Neurobiol Dis 2017;97:46-59. [PMID: 27818324 DOI: 10.1016/j.nbd.2016.10.006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 10.0] [Reference Citation Analysis]
200 Bechthold E, Schreiber JA, Ritter N, Grey L, Schepmann D, Daniliuc C, González-cano R, Nieto FR, Seebohm G, Wünsch B. Synthesis of tropane-based σ1 receptor antagonists with antiallodynic activity. European Journal of Medicinal Chemistry 2022;230:114113. [DOI: 10.1016/j.ejmech.2022.114113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Romeo G, Bonanno F, Wilson LL, Arena E, Modica MN, Pittalà V, Salerno L, Prezzavento O, McLaughlin JP, Intagliata S. Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects. ACS Chem Neurosci 2021;12:2003-12. [PMID: 34019387 DOI: 10.1021/acschemneuro.1c00106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
202 Conroy T, Manohar M, Gong Y, Wilkinson SM, Webster M, Lieberman BP, Banister SD, Reekie TA, Mach RH, Rendina LM, Kassiou M. A systematic exploration of the effects of flexibility and basicity on sigma (σ) receptor binding in a series of substituted diamines. Org Biomol Chem 2016;14:9388-405. [PMID: 27714195 DOI: 10.1039/c6ob00615a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
203 Sharma N, Patel C, Shenkman M, Kessel A, Ben-Tal N, Lederkremer GZ. The Sigma-1 receptor is an ER-localized type II membrane protein. J Biol Chem 2021;297:101299. [PMID: 34648767 DOI: 10.1016/j.jbc.2021.101299] [Reference Citation Analysis]
204 Zha J, Li D. Lipid Cubic Phase for Membrane Protein X-ray Crystallography. In: Wang H, Li G, editors. Membrane Biophysics. Singapore: Springer; 2018. pp. 175-220. [DOI: 10.1007/978-981-10-6823-2_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
205 Hayashi T. The Sigma-1 Receptor in Cellular Stress Signaling. Front Neurosci 2019;13:733. [PMID: 31379486 DOI: 10.3389/fnins.2019.00733] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
206 Fanter L, Müller C, Schepmann D, Bracher F, Wünsch B. Chiral-pool synthesis of 1,2,4-trisubstituted 1,4-diazepanes as novel σ1 receptor ligands. Bioorganic & Medicinal Chemistry 2017;25:4778-99. [DOI: 10.1016/j.bmc.2017.07.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
207 Cifani C, Micioni Di Bonaventura E, Botticelli L, Del Bello F, Giorgioni G, Pavletić P, Piergentili A, Quaglia W, Bonifazi A, Schepmann D, Wünsch B, Vistoli G, Micioni Di Bonaventura MV. Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats. ACS Chem Neurosci 2020;11:3107-16. [PMID: 32886484 DOI: 10.1021/acschemneuro.0c00456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
208 Zampieri D, Fortuna S, Calabretti A, Romano M, Menegazzi R, Schepmann D, Wünsch B, Mamolo MG. Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands. ACS Med Chem Lett 2020;11:651-6. [PMID: 32435366 DOI: 10.1021/acsmedchemlett.9b00524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
209 Dasargyri A, Kümin CD, Leroux JC. Targeting Nanocarriers with Anisamide: Fact or Artifact? Adv Mater 2017;29. [PMID: 27885719 DOI: 10.1002/adma.201603451] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
210 Jia H, Zhang Y, Huang Y. Imaging sigma receptors in the brain: New opportunities for diagnosis of Alzheimer's disease and therapeutic development. Neurosci Lett 2019;691:3-10. [PMID: 30040970 DOI: 10.1016/j.neulet.2018.07.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
211 Kopp N, Civenni G, Marson D, Laurini E, Pricl S, Catapano CV, Humpf HU, Almansa C, Nieto FR, Schepmann D, Wünsch B. Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ1 receptor affinity, antitumor and analgesic activity. Eur J Med Chem 2021;219:113443. [PMID: 33901806 DOI: 10.1016/j.ejmech.2021.113443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Ryskamp DA, Korban S, Zhemkov V, Kraskovskaya N, Bezprozvanny I. Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases. Front Neurosci 2019;13:862. [PMID: 31551669 DOI: 10.3389/fnins.2019.00862] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 14.0] [Reference Citation Analysis]
213 Bae HE, Du Y, Hariharan P, Mortensen JS, Kumar KK, Ha B, Das M, Lee HS, Loland CJ, Guan L, Kobilka BK, Chae PS. Asymmetric maltose neopentyl glycol amphiphiles for a membrane protein study: effect of detergent asymmetricity on protein stability. Chem Sci 2019;10:1107-16. [PMID: 30774908 DOI: 10.1039/c8sc02560f] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
214 Bergkemper M, Kronenberg E, Schepmann D, Ludwig FA, Brust P, Wünsch B. Structure-Affinity Relationships of Fluorinated Spirocyclic σ2 Receptor Ligands with an Exocyclic Benzylamino Moiety. ChemMedChem 2019;14:1392-402. [PMID: 31189022 DOI: 10.1002/cmdc.201900284] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Voronin MV, Vakhitova YV, Seredenin SB. Chaperone Sigma1R and Antidepressant Effect. Int J Mol Sci 2020;21:E7088. [PMID: 32992988 DOI: 10.3390/ijms21197088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
216 Agha H, McCurdy CR. In vitro and in vivo sigma 1 receptor imaging studies in different disease states. RSC Med Chem 2021;12:154-77. [PMID: 34046607 DOI: 10.1039/d0md00186d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
217 Rescifina A, Floresta G, Marrazzo A, Parenti C, Prezzavento O, Nastasi G, Dichiara M, Amata E. Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis. European Journal of Pharmaceutical Sciences 2017;106:94-101. [DOI: 10.1016/j.ejps.2017.05.061] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
218 Rodríguez-Muñoz M, Cortés-Montero E, Garzón-Niño J, Sánchez-Blázquez P. The ALS-related σ1R E102Q Mutant Eludes Ligand Control and Exhibits Anomalous Response to Calcium. Int J Mol Sci 2020;21:E7339. [PMID: 33020464 DOI: 10.3390/ijms21197339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Shi M, Chen F, Chen Z, Yang W, Yue S, Zhang J, Chen X. Sigma-1 Receptor: A Potential Therapeutic Target for Traumatic Brain Injury. Front Cell Neurosci 2021;15:685201. [PMID: 34658788 DOI: 10.3389/fncel.2021.685201] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Wang YM, Xia CY, Jia HM, He J, Lian WW, Yan Y, Wang WP, Zhang WK, Xu JK. Sigma-1 receptor: A potential target for the development of antidepressants. Neurochem Int 2022;159:105390. [PMID: 35810915 DOI: 10.1016/j.neuint.2022.105390] [Reference Citation Analysis]
221 Xu K, Hsieh CJ, Lee JY, Riad A, Izzo NJ, Look G, Catalano S, Mach RH. Exploration of Diazaspiro Cores as Piperazine Bioisosteres in the Development of σ2 Receptor Ligands. Int J Mol Sci 2022;23:8259. [PMID: 35897835 DOI: 10.3390/ijms23158259] [Reference Citation Analysis]
222 Wang J, Zhao J, Cui X, Mysona BA, Navneet S, Saul A, Ahuja M, Lambert N, Gazaryan IG, Thomas B, Bollinger KE, Smith SB. The molecular chaperone sigma 1 receptor mediates rescue of retinal cone photoreceptor cells via modulation of NRF2. Free Radic Biol Med 2019;134:604-16. [PMID: 30743048 DOI: 10.1016/j.freeradbiomed.2019.02.001] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
223 Arena E, Cacciatore I, Cerasa LS, Turkez H, Pittalà V, Pasquinucci L, Marrazzo A, Parenti C, Di Stefano A, Prezzavento O. New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation. Bioorg Med Chem 2016;24:3149-56. [PMID: 27262426 DOI: 10.1016/j.bmc.2016.05.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
224 Song L, Bekdash R, Morikawa K, Quejada JR, Klein AD, Aina-badejo D, Yoshida K, Yamamoto HE, Chalan A, Yang R, Patel A, Sirabella D, Lee TM, Joseph LC, Kawano F, Warren JS, Soni RK, Morrow JP, Yazawa M. Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome. Nat Cardiovasc Res 2022;1:142-56. [DOI: 10.1038/s44161-021-00016-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Murineddu G, Deligia F, Ragusa G, García-toscano L, Gómez-cañas M, Asproni B, Satta V, Cichero E, Pazos R, Fossa P, Loriga G, Fernández-ruiz J, Pinna GA. Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB 1 receptor ligand antagonists. Bioorganic & Medicinal Chemistry 2018;26:295-307. [DOI: 10.1016/j.bmc.2017.11.051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
226 Arena E, Dichiara M, Floresta G, Parenti C, Marrazzo A, Pittalà V, Amata E, Prezzavento O. Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new? Future Medicinal Chemistry 2018;10:231-56. [DOI: 10.4155/fmc-2017-0164] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
227 Lee PT, Liévens JC, Wang SM, Chuang JY, Khalil B, Wu HE, Chang WC, Maurice T, Su TP. Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models. Nat Commun 2020;11:5580. [PMID: 33149115 DOI: 10.1038/s41467-020-19396-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
228 Kronenberg E, Weber F, Brune S, Schepmann D, Almansa C, Friedland K, Laurini E, Pricl S, Wünsch B. Synthesis and Structure-Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety. J Med Chem 2019;62:4204-17. [PMID: 30939014 DOI: 10.1021/acs.jmedchem.9b00449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
229 Pan L, Pasternak DA, Xu J, Xu M, Lu Z, Pasternak GW, Pan YX. Isolation and characterization of alternatively spliced variants of the mouse sigma1 receptor gene, Sigmar1. PLoS One 2017;12:e0174694. [PMID: 28350844 DOI: 10.1371/journal.pone.0174694] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
230 Kopp N, Holtschulte C, Börgel F, Lehmkuhl K, Friedland K, Civenni G, Laurini E, Catapano CV, Pricl S, Humpf HU, Schepmann D, Wünsch B. Novel σ1 antagonists designed for tumor therapy: Structure - activity relationships of aminoethyl substituted cyclohexanes. Eur J Med Chem 2021;210:112950. [PMID: 33148494 DOI: 10.1016/j.ejmech.2020.112950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
231 Blass BE, Rogers JP. The sigma-2 (σ-2) receptor: a review of recent patent applications: 2013–2018. Expert Opinion on Therapeutic Patents 2018;28:655-63. [DOI: 10.1080/13543776.2018.1519024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
232 Boido V, Ercoli M, Tonelli M, Novelli F, Tasso B, Sparatore F, Cichero E, Fossa P, Dorigo P, Froldi G. New arylsparteine derivatives as positive inotropic drugs. J Enzyme Inhib Med Chem 2017;32:588-99. [PMID: 28133984 DOI: 10.1080/14756366.2017.1279156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
233 Sun H, Wang Y, Shi W, Yang F, Tang J, Pang T, Yu L. Discovery of N -cyclobutylaminoethoxyisoxazole derivatives as novel sigma-1 receptor ligands with neurite outgrowth efficacy in cells. RSC Adv 2018;8:7080-8. [DOI: 10.1039/c8ra00072g] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
234 Borbély E, Varga V, Szögi T, Schuster I, Bozsó Z, Penke B, Fülöp L. Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1-42-Injected, Wild-Type Mouse Model of AD. Int J Mol Sci 2022;23:2514. [PMID: 35269657 DOI: 10.3390/ijms23052514] [Reference Citation Analysis]
235 Bunse P, Schlepphorst C, Glorius F, Kitamura M, Wünsch B. Short and Atom-Economic Enantioselective Synthesis of the σ1-Receptor Ligands (S)- and (R)-Fluspidine-Important Tools for Positron Emission Tomography Studies. J Org Chem 2019;84:13744-54. [PMID: 31523971 DOI: 10.1021/acs.joc.9b01882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
236 Brimson JM, Brimson S, Chomchoei C, Tencomnao T. Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain. Expert Opin Ther Targets 2020;24:1009-28. [PMID: 32746649 DOI: 10.1080/14728222.2020.1805435] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
237 Fan Y, Simmen T. Mechanistic Connections between Endoplasmic Reticulum (ER) Redox Control and Mitochondrial Metabolism. Cells 2019;8:E1071. [PMID: 31547228 DOI: 10.3390/cells8091071] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
238 Yano H, Liu L, Naing S, Shi L. The Effects of Terminal Tagging on Homomeric Interactions of the Sigma 1 Receptor. Front Neurosci 2019;13:1356. [PMID: 31920515 DOI: 10.3389/fnins.2019.01356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
239 Abate C, Niso M, Berardi F. Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations. Future Medicinal Chemistry 2018;10:1997-2018. [DOI: 10.4155/fmc-2018-0072] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
240 Wang J, Saul A, Cui X, Roon P, Smith SB. Absence of Sigma 1 Receptor Accelerates Photoreceptor Cell Death in a Murine Model of Retinitis Pigmentosa. Invest Ophthalmol Vis Sci 2017;58:4545-58. [PMID: 28877319 DOI: 10.1167/iovs.17-21947] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
241 Shacham T, Sharma N, Lederkremer GZ. Protein Misfolding and ER Stress in Huntington's Disease. Front Mol Biosci 2019;6:20. [PMID: 31001537 DOI: 10.3389/fmolb.2019.00020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
242 Aydar E, Cobos EJ, Maurice T, Murell-Lagnado RD, Safrany ST. Editorial: Sigma Receptors. Front Pharmacol 2020;11:590519. [PMID: 33013426 DOI: 10.3389/fphar.2020.590519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Rodríguez-Muñoz M, Sánchez-Blázquez P, Merlos M, Garzón-Niño J. Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. Oncotarget 2016;7:55840-62. [PMID: 27323834 DOI: 10.18632/oncotarget.10095] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 11.5] [Reference Citation Analysis]
244 Pontisso I, Combettes L. Role of Sigma-1 Receptor in Calcium Modulation: Possible Involvement in Cancer. Genes (Basel) 2021;12:139. [PMID: 33499031 DOI: 10.3390/genes12020139] [Reference Citation Analysis]
245 Hong WC. Distinct Regulation of σ 1 Receptor Multimerization by Its Agonists and Antagonists in Transfected Cells and Rat Liver Membranes. J Pharmacol Exp Ther 2020;373:290-301. [PMID: 32060048 DOI: 10.1124/jpet.119.262790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
246 Ogawa K, Masuda R, Mishiro K, Wang M, Kozaka T, Shiba K, Kinuya S, Odani A. Syntheses and evaluation of a homologous series of aza-vesamicol as improved radioiodine-labeled probes for sigma-1 receptor imaging. Bioorg Med Chem 2019;27:1990-6. [PMID: 30975500 DOI: 10.1016/j.bmc.2019.03.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
247 Donnier-Maréchal M, Carato P, Larchanché PE, Ravez S, Boulahjar R, Barczyk A, Oxombre B, Vermersch P, Melnyk P. Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 protein ligands. Eur J Med Chem 2017;138:964-78. [PMID: 28756263 DOI: 10.1016/j.ejmech.2017.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
248 Penke B, Fulop L, Szucs M, Frecska E. The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases. Curr Neuropharmacol 2018;16:97-116. [PMID: 28554311 DOI: 10.2174/1570159X15666170529104323] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
249 Herrando-Grabulosa M, Gaja-Capdevila N, Vela JM, Navarro X. Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis. Br J Pharmacol 2021;178:1336-52. [PMID: 32761823 DOI: 10.1111/bph.15224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
250 López-Estévez S, Gris G, de la Puente B, Carceller A, Martínez V. Intestinal inflammation-associated hypersensitivity is attenuated in a DSS model of colitis in Sigma-1 knockout C57BL/6 mice. Biomed Pharmacother 2021;143:112126. [PMID: 34474349 DOI: 10.1016/j.biopha.2021.112126] [Reference Citation Analysis]
251 Turnaturi R, Montenegro L, Marrazzo A, Parenti R, Pasquinucci L, Parenti C. Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review. Eur J Med Chem 2018;155:492-502. [PMID: 29908442 DOI: 10.1016/j.ejmech.2018.06.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
252 Wang J, Saul A, Smith SB. Activation of Sigma 1 Receptor Extends Survival of Cones and Improves Visual Acuity in a Murine Model of Retinitis Pigmentosa. Invest Ophthalmol Vis Sci 2019;60:4397-407. [PMID: 31639826 DOI: 10.1167/iovs.19-27709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
253 Lepelletier FX, Vandesquille M, Asselin MC, Prenant C, Robinson AC, Mann DMA, Green M, Barnett E, Banister SD, Mottinelli M, Mesangeau C, McCurdy CR, Fricke IB, Jacobs AH, Kassiou M, Boutin H. Evaluation of 18F-IAM6067 as a sigma-1 receptor PET tracer for neurodegeneration in vivo in rodents and in human tissue. Theranostics 2020;10:7938-55. [PMID: 32724451 DOI: 10.7150/thno.47585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
254 Rehman M, Vodret S, Braga L, Guarnaccia C, Celsi F, Rossetti G, Martinelli V, Battini T, Long C, Vukusic K, Kocijan T, Collesi C, Ring N, Skoko N, Giacca M, Del Sal G, Confalonieri M, Raspa M, Marcello A, Myers MP, Crovella S, Carloni P, Zacchigna S. High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation. JCI Insight 2019;4:123987. [PMID: 30996132 DOI: 10.1172/jci.insight.123987] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
255 Wang T, Zhang Y, Zhang X, Chen L, Zheng M, Zhang J, Brust P, Deuther-conrad W, Huang Y, Jia H. Synthesis and characterization of the two enantiomers of a chiral sigma-1 receptor radioligand: (S)-(+)- and (R)-(-)-[18F]FBFP. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.03.099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
256 Brimson JM, Akula KK, Abbas H, Ferry DR, Kulkarni SK, Russell ST, Tisdale MJ, Tencomnao T, Safrany ST. Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression. Sci Rep 2020;10:9251. [PMID: 32514120 DOI: 10.1038/s41598-020-65849-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
257 Zampieri D, Fortuna S, Calabretti A, Romano M, Menegazzi R, Schepmann D, Wünsch B, Collina S, Zanon D, Mamolo MG. Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents. Eur J Med Chem 2019;180:268-82. [PMID: 31319263 DOI: 10.1016/j.ejmech.2019.07.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
258 Ye N, Qin W, Tian S, Xu Q, Wold EA, Zhou J, Zhen XC. Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. J Med Chem 2020;63:15187-217. [PMID: 33111525 DOI: 10.1021/acs.jmedchem.0c01192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
259 Nastasi G, Miceli C, Pittalà V, Modica MN, Prezzavento O, Romeo G, Rescifina A, Marrazzo A, Amata E. S2RSLDB: a comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands. J Cheminform 2017;9:3. [PMID: 28123452 DOI: 10.1186/s13321-017-0191-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
260 Alon A, Schmidt HR, Wood MD, Sahn JJ, Martin SF, Kruse AC. Identification of the gene that codes for the σ2 receptor. Proc Natl Acad Sci U S A 2017;114:7160-5. [PMID: 28559337 DOI: 10.1073/pnas.1705154114] [Cited by in Crossref: 142] [Cited by in F6Publishing: 132] [Article Influence: 28.4] [Reference Citation Analysis]
261 Pascual R, Almansa C, Plata-Salamán C, Vela JM. A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset. Front Pharmacol 2019;10:519. [PMID: 31214020 DOI: 10.3389/fphar.2019.00519] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
262 Riddy DM, Cook AE, Shackleford DM, Pierce TL, Mocaer E, Mannoury la Cour C, Sors A, Charman WN, Summers RJ, Sexton PM, Christopoulos A, Langmead CJ. Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists. Neuropharmacology 2019;144:244-55. [PMID: 30359639 DOI: 10.1016/j.neuropharm.2018.10.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
263 Li Volti G, Murabito P. Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects. Neural Regen Res 2016;11:1392-3. [PMID: 27857729 DOI: 10.4103/1673-5374.191200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
264 Peng Y, Dong H, Welsh WJ. Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands. J Chem Inf Model 2019;59:486-97. [PMID: 30497261 DOI: 10.1021/acs.jcim.8b00521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
265 Greenfield DA, Schmidt HR, Skiba MA, Mandler MD, Anderson JR, Sliz P, Kruse AC. Virtual Screening for Ligand Discovery at the σ1 Receptor. ACS Med Chem Lett 2020;11:1555-61. [PMID: 32832023 DOI: 10.1021/acsmedchemlett.9b00314] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
266 Meng F, Xiao Y, Ji Y, Sun Z, Zhou X. An open-like conformation of the sigma-1 receptor reveals its ligand entry pathway. Nat Commun 2022;13:1267. [PMID: 35273182 DOI: 10.1038/s41467-022-28946-w] [Reference Citation Analysis]
267 Velázquez-Libera JL, Rossino G, Navarro-Retamal C, Collina S, Caballero J. Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33. Front Chem 2019;7:496. [PMID: 31355187 DOI: 10.3389/fchem.2019.00496] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
268 Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T. Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis. Molecules 2020;25:E5439. [PMID: 33233619 DOI: 10.3390/molecules25225439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
269 Abdullah CS, Aishwarya R, Alam S, Remex NS, Morshed M, Nitu S, Miriyala S, Panchatcharam M, Hartman B, King J, Alfrad Nobel Bhuiyan M, Traylor J, Kevil CG, Orr AW, Bhuiyan MS. The molecular role of Sigmar1 in regulating mitochondrial function through mitochondrial localization in cardiomyocytes. Mitochondrion 2022;62:159-75. [PMID: 34902622 DOI: 10.1016/j.mito.2021.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Luo G, Zhang J, Sun Y, Wang Y, Wang H, Cheng B, Shu Q, Fang X. Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis. Nanomicro Lett 2021;13:88. [PMID: 34138348 DOI: 10.1007/s40820-021-00598-3] [Reference Citation Analysis]
271 Schmidt HR, Betz RM, Dror RO, Kruse AC. Structural basis for σ1 receptor ligand recognition. Nat Struct Mol Biol 2018;25:981-7. [PMID: 30291362 DOI: 10.1038/s41594-018-0137-2] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 12.3] [Reference Citation Analysis]
272 Díaz JL, Corbera J, Cuberes R, Contijoch M, Enrech R, Yeste S, Montero A, Dordal A, Monroy X, Almansa C. Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 1: 4-acylamino derivatives. Medchemcomm 2017;8:1235-45. [PMID: 30108834 DOI: 10.1039/c7md00077d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
273 Delint-Ramirez I, Garcia-Oscos F, Segev A, Kourrich S. Cocaine engages a non-canonical, dopamine-independent, mechanism that controls neuronal excitability in the nucleus accumbens. Mol Psychiatry 2020;25:680-91. [PMID: 29880884 DOI: 10.1038/s41380-018-0092-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
274 Kumar S, Javed R, Mudd M, Pallikkuth S, Lidke KA, Jain A, Tangavelou K, Gudmundsson SR, Ye C, Rusten TE, Anonsen JH, Lystad AH, Claude-Taupin A, Simonsen A, Salemi M, Phinney B, Li J, Guo LW, Bradfute SB, Timmins GS, Eskelinen EL, Deretic V. Mammalian hybrid pre-autophagosomal structure HyPAS generates autophagosomes. Cell 2021;184:5950-5969.e22. [PMID: 34741801 DOI: 10.1016/j.cell.2021.10.017] [Reference Citation Analysis]
275 Tesei A, Cortesi M, Zamagni A, Arienti C, Pignatta S, Zanoni M, Paolillo M, Curti D, Rui M, Rossi D, Collina S. Sigma Receptors as Endoplasmic Reticulum Stress "Gatekeepers" and their Modulators as Emerging New Weapons in the Fight Against Cancer. Front Pharmacol 2018;9:711. [PMID: 30042674 DOI: 10.3389/fphar.2018.00711] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
276 Abbas H, Borde P, Willars GB, Ferry DR, Safrany ST. Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors. Front Pharmacol 2020;11:309. [PMID: 32231573 DOI: 10.3389/fphar.2020.00309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
277 Ke M, He G, Wang H, Cheng S, Xu Y. Sigma receptor knockdown augments dysfunction and apoptosis of beta cells induced by palmitate. Exp Biol Med (Maywood) 2021;246:1491-9. [PMID: 33715527 DOI: 10.1177/1535370221997780] [Reference Citation Analysis]
278 Schmidt HR, Kruse AC. The Molecular Function of σ Receptors: Past, Present, and Future. Trends Pharmacol Sci 2019;40:636-54. [PMID: 31387763 DOI: 10.1016/j.tips.2019.07.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 15.7] [Reference Citation Analysis]
279 Mavylutov T, Chen X, Guo L, Yang J. APEX2- tagging of Sigma 1-receptor indicates subcellular protein topology with cytosolic N-terminus and ER luminal C-terminus. Protein Cell 2018;9:733-7. [PMID: 28929457 DOI: 10.1007/s13238-017-0468-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
280 Smith SB, Wang J, Cui X, Mysona BA, Zhao J, Bollinger KE. Sigma 1 receptor: A novel therapeutic target in retinal disease. Prog Retin Eye Res 2018;67:130-49. [PMID: 30075336 DOI: 10.1016/j.preteyeres.2018.07.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
281 Brailoiu E, Chakraborty S, Brailoiu GC, Zhao P, Barr JL, Ilies MA, Unterwald EM, Abood ME, Taylor CW. Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors. Cell Rep 2019;26:330-337.e4. [PMID: 30625315 DOI: 10.1016/j.celrep.2018.12.051] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]